SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-001546
Filing Date
2021-03-04
Accepted
2021-03-04 16:10:12
Documents
14
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_030421.htm   iXBRL 8-K 14940
2 PRESS RELEASE exh_991.htm EX-99.1 202288
  Complete submission text file 0001171843-21-001546.txt   434257

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3095
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25969
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 35566
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 24600
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_030421_htm.xml XML 3029
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 21714244
SIC: 3841 Surgical & Medical Instruments & Apparatus